HER2+ METASTATIC BREAST CANCER (MBC)

Clinical trials for HER2+ METASTATIC BREAST CANCER (MBC) explained in plain language.

Never miss a new study

Get alerted when new HER2+ METASTATIC BREAST CANCER (MBC) trials appear

Sign up with your email to follow new studies for HER2+ METASTATIC BREAST CANCER (MBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New Nurse-Led program aims to guide women through advanced breast cancer treatment

Symptom relief Not yet recruiting

This study is testing a new support program led by nurses for women with advanced HER2+ breast cancer who are taking a specific drug combination. The program aims to help patients better understand their treatment, manage side effects, stick to their medication schedule, and cope…

Matched conditions: HER2+ METASTATIC BREAST CANCER (MBC)

Phase: NA • Sponsor: Duke University • Aim: Symptom relief

Last updated Mar 17, 2026 13:09 UTC

HER2+ METASTATIC BREAST CANCER (MBC)

Get alerted when new HER2+ METASTATIC BREAST CANCER (MBC) trials appear

New Nurse-Led program aims to guide women through advanced breast cancer treatment